US Broker Ratings

Immunome, Inc. (IMNM) Stock Analysis: Unpacking the 189.60% Potential Upside

Immunome, Inc. (NASDAQ: IMNM), a clinical-stage biotechnology firm, is making waves in the healthcare sector with a promising pipeline aimed at developing targeted cancer therapies. With a market capitalization of..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Exploring a Promising 58% Upside Potential

LENZ Therapeutics, Inc. (NASDAQ: LENZ) is generating significant buzz among investors, promising a potential upside of 58.13%. This biopharmaceutical company, headquartered in Solana Beach, California, is carving its niche in..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: Exploring a Biotech Gem with 12.20% Potential Upside

Niagen Bioscience, Inc. (NAGE), a Los Angeles-based biotech company specializing in healthy aging products, has been catching the eye of investors with its promising potential upside of 12.20%. Operating in..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: Biotechnology Innovator with a 242% Potential Upside

Trevi Therapeutics, Inc. (NASDAQ: TRVI) is making waves in the healthcare sector with its innovative approach to treating chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and other challenging..

Pharvaris N.V. (PHVS) Stock Analysis: Potential 107.91% Upside Amid Biotech Advancements

Pharvaris N.V. (PHVS), a promising player in the biotechnology sector, is attracting substantial investor attention with a potential upside of 107.91%, according to analyst ratings. As a late-stage biopharmaceutical company..

Bicara Therapeutics Inc. (BCAX) Investor Outlook: Exploring a 108% Potential Upside in Biotech Innovation

Bicara Therapeutics Inc. (NASDAQ: BCAX), a burgeoning name in the biotechnology sector, stands at an intriguing juncture for investors looking to capitalize on its innovative approach to cancer treatment. With..

Day One Biopharmaceuticals, Inc. (DAWN) Stock Analysis: Exploring a Potential 346% Upside

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN), a burgeoning player in the biotechnology sector, is attracting significant attention from investors due to its promising pipeline and the compelling potential upside of..

CareDx, Inc. (CDNA) Stock Analysis: A 71% Upside Potential Awaits Investors

CareDx, Inc. (NASDAQ: CDNA), a prominent player in the healthcare sector specializing in diagnostics and research, has captured investor attention with its innovative solutions for transplant patients. With a market..

Nutex Health Inc. (NUTX) Stock Analysis: Exploring a 53% Upside Potential with Robust Revenue Growth

Nutex Health Inc. (NUTX), a dynamic player in the healthcare sector, has captured investor attention with its robust revenue growth and significant upside potential. Despite recent fluctuations, the company stands..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Navigating the Challenges with a Strategic Outlook

Phibro Animal Health Corporation (NASDAQ: PAHC) presents a nuanced opportunity for investors in the healthcare sector, particularly within the niche of drug manufacturers for specialty and generic products. With a..

Arcus Biosciences, Inc. (RCUS) Stock Analysis: A Bold Bet with 220% Potential Upside

Arcus Biosciences, Inc. (NASDAQ: RCUS), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its ambitious cancer therapy pipeline. Specializing in the development and commercialization of innovative..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: A Biotech Contender with 154.94% Potential Upside

Praxis Precision Medicines, Inc (NASDAQ: PRAX) is carving a niche in the biotechnology sector with its focus on central nervous system (CNS) disorders. As a clinical-stage biopharmaceutical company, Praxis is..

Cronos Group Inc. (CRON) Stock Analysis: Revenue Growth Amid Potential Downsides

Cronos Group Inc. (NASDAQ: CRON), a key player in the healthcare sector’s specialty and generic drug manufacturing industry, has been making waves with its focus on cannabinoid products. With a..

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: Unveiling a 203% Potential Upside in the Biotech Arena

For investors with a keen eye on the biotech sector, Nurix Therapeutics, Inc. (NASDAQ: NRIX) presents a compelling opportunity. The company’s focus on innovative small molecule and antibody therapies positions..

InMode Ltd. (INMD) Stock Analysis: Exploring a 20% Potential Upside in the Medical Devices Sector

InMode Ltd. (NASDAQ: INMD), a prominent player in the medical devices sector, is capturing the attention of investors with its innovative aesthetic medical products and a significant potential upside. Headquartered..

Enliven Therapeutics (ELVN) Stock Analysis: Exploring a 123% Potential Upside in Biotech

Enliven Therapeutics, Inc. (NASDAQ: ELVN) presents a compelling opportunity for investors seeking exposure to the biotechnology sector. With a market capitalization of $822.89 million, this clinical-stage biopharmaceutical company is making..

STAAR Surgical Company (STAA) Stock Analysis: Navigating Challenges with an Eye on Growth

STAAR Surgical Company (NASDAQ: STAA), a prominent player in the healthcare sector specializing in medical instruments and supplies, is known for its innovative approach in the vision correction industry. This..

PAR Technology Corporation (PAR) Stock Analysis: Exploring a 32% Potential Upside for Investors

PAR Technology Corporation (NYSE: PAR), a formidable player in the Technology sector and a leading entity in the Software – Application industry, is catching the attention of investors with its..

DoubleVerify Holdings, Inc. (DV) Stock Analysis: Unpacking a Potential 35% Upside in the Digital Media Landscape

DoubleVerify Holdings, Inc. (NYSE: DV) is strategically positioned within the technology sector, specifically in the software application industry. As the digital advertising landscape continues to evolve, DoubleVerify’s robust suite of..

Alkami Technology, Inc. (ALKT) Stock Analysis: A 31.61% Potential Upside Beckons Investors

Alkami Technology, Inc. (NASDAQ: ALKT), a prominent player in the application software industry, is garnering attention with its robust growth prospects and significant upside potential. As a leader in cloud-based..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds